Next generation sequencing to determine the cystic fibrosis mutation spectrum in Palestinian population

O. Essawi, M. Farraj, K. De Leeneer, W. Steyaert, K. De Pauw, A. De Paepe, K. Claes, T. Essawi, P. J. Coucke*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


An extensive molecular analysis of the CF transmembrane regulator (CFTR) gene was performed to establish the CFTR mutation spectrumand frequencies in the Palestinian population, which can be considered as an understudied population.We used a targeted NextGeneration Sequencing approach to sequence the entire coding region and the adjacent sequences of the CFTR gene combined with MLPA analysis of 60 unrelated CF patients. Eighteen different CF-causing mutations, including one previously undescribed mutation p.(Gly1265Arg), were identified. The overall detection rate is up to 67%, and when we consider only CF patients with sweat chloride concentrations >70mEq/L, we even have a pickup rate of 92%. Whereas p.(Phe508del) is the most frequent allele (35% of the positive cases), 3 othermutations c.2988+1Kbdel8.6Kb, c.1393-1G>A, and p.(Gly85Glu) showed frequencies higher than 5% and a total of 9 mutations account for 84% of the mutations. This limited spectrum of CF mutations is in agreement with the homozygous ethnic origin of the Palestinian population. The relative large portion of patients without a mutation is most likely due to clinical misdiagnosis. Our results will be important in the development of an adequate molecular diagnostic test for CF in Palestine.

Original languageEnglish
Article number458653
JournalDisease Markers
StatePublished - 2015
Externally publishedYes


Dive into the research topics of 'Next generation sequencing to determine the cystic fibrosis mutation spectrum in Palestinian population'. Together they form a unique fingerprint.

Cite this